TAMPA,
Fla., Oct. 3, 2024 /PRNewswire/ -- In
recognition of Thyroid Cancer Awareness Month, the Clayman
Thyroid Center, in partnership with the Hospital for Endocrine
Surgery, is proud to announce the opening of a state-of-the-art
Research Institute dedicated to clinical trials and research of
endocrine diseases, with a primary focus on thyroid cancer.
This Institute represents a significant
step forward in our fight against thyroid cancer and other
endocrine diseases.
The Research Institute at the Hospital for Endocrine Surgery
opens just 2.5 years after the opening of the new state of the art
endocrine hospital which specializes in curative surgery for tumors
of the thyroid, parathyroid and adrenal glands. Thyroid cancer
is one of the fastest-growing cancers globally, with a
particularly high incidence among women. The new Research Institute
will serve as a hub for groundbreaking research and innovative
clinical trials that aim to advance the understanding, diagnosis,
and treatment of thyroid cancer and other endocrine diseases.
"We are excited to leverage our position as the highest-volume
thyroid surgeons in the world to drive significant advancements in
thyroid cancer research," said Dr. Gary
Clayman, founder of the Clayman Thyroid Center. "With over
2,000 thyroid cancer operations performed annually, our unmatched
patient volume uniquely positions us to expedite clinical trials,
bringing cutting-edge treatments to patients more quickly and
unlocking new insights into the biology and treatment of thyroid
cancers."
Fabio Faucz, PhD was recruited
from his leadership position at the NIH to lead the Research
Institute. "This Institute represents a significant step forward in
our fight against thyroid cancer and other endocrine diseases. Our
goal is to foster a collaborative environment where innovative
ideas can flourish, and where our research can translate into
tangible benefits for patients. We are committed to pushing the
boundaries of what is possible in thyroid cancer treatment and
research, and I am honored to lead this initiative."
The new Research Institute will have a heavy emphasis on cancer
genetics with the development of the world's largest biobanking of
thyroid cancers allowing for personalized cancer treatments based
upon individual cancer genetics. By accelerating the pace of
research, the Institute is committed to transforming the landscape
of thyroid cancer care and offering new hope to patients
worldwide.
The Clayman Thyroid Center's surgeons operate exclusively at the
Hospital for Endocrine Surgery in Tampa,
Florida alongside their sister surgeons of the Norman
Parathyroid Center and the Carling Adrenal Center. Together, they
are the highest volume endocrine surgery practice in the world
which will provide the Research Institute unprecedented access to
thyroid, parathyroid and adrenal tumors.
About the Clayman Thyroid Center:
Founded by one of the nation's best-known thyroid surgeons, the
Clayman Thyroid Center is the highest volume thyroid cancer
referral center in the United
States. The Center boasts the most experienced thyroid
surgeons in the US who provide personalized care allowing the
greatest opportunity for cancer cure, wellness, and cosmetic, and
functional, outcomes via all types of thyroid surgery from minimal
incision to scarless thyroid surgery to advanced cancer care.
www.thyroidcancer.com | (813) 940-3130
About the Hospital for Endocrine Surgery
The Hospital for Endocrine Surgery is a campus of HCA Florida South
Tampa Hospital focused on compassionate patient care and highly
specialized treatment of endocrine tumors. We provide a wide array
of services necessary for the diagnosis and surgical treatment of
tumors of the thyroid, parathyroid, and adrenal glands. Our team
includes doctors, surgeons, nurses, and technicians who have
dedicated their careers to delivering the highest cure rates using
the most advanced techniques available. HCA's Hospital for
Endocrine Surgery is the nation's highest-volume hospital for
thyroid, parathyroid, and adrenal tumors and cancers.
www.hospitalforendocrinesurgery.com
Media Contact:
Julie Canan, Director of
Marketing
941.468.3002 | juliec@parathyroid.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/hospital-for-endocrine-surgery-opens-new-research-institute-to-combat-thyroid-cancer-302267719.html
SOURCE Clayman Thyroid Center